Rahul Ray | Profiles RNS

Rahul Ray, PhD

Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Endocrinology, Diabetes, Nutrition & Weight Management

PhD, Washington State University
MSc, University of Calcutta
BSc, Presidency College

Websites

	LinkedIn
	ResearchGate

ORCID : 0000-0002-2078-2201

Expertise includes: Nanomedicine; Cancer drug therapeutics; Targeted drug delivery.

Research Professor
Boston University Chobanian & Avedisian School of Medicine
Pharmacology, Physiology & Biophysics

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Boston Medical Center

BU Research
NIH RePORTER Research

Structure-Function Studies of Vitamin D-Binding Protein
05/01/1997 - 04/30/2002 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK44337 07

Title

Yr	Title	Project-Sub Proj	Pubs
2009	Novel vitamin D analog for kidney cancer	5R21CA127629-02	4
2008	Novel vitamin D analog for kidney cancer	1R21CA127629-01A2	4
2000	STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN	5R01DK044337-07	23
1999	MOLECULAR PROBING OF VITAMIN D RECEPTOR	3R01DK047418-04S3	20
1999	STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN	5R01DK044337-06	23
1998	MOLECULAR PROBING OF VITAMIN D RECEPTOR	3R01DK047418-04S2	20
1998	STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN	5R01DK044337-05	23
1997	MOLECULAR PROBING OF VITAMIN D RECEPTOR	5R01DK047418-04	20
1997	MOLECULAR PROBING OF VITAMIN D RECEPTOR	3R01DK047418-04S1	20
1997	STRUCTURE/FUNCTION STUDIES OF VITAMIN D BINDING PROTEIN	3R01DK044337-04A2S1	23

Showing 10 of 22 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Gari HH, DeGala GD, Ray R, Lucia MS, Lambert JR. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion. Cancer Lett. 2016 Oct 01; 380(2):505-12. PMID: 27452906; PMCID: PMC5497588; DOI: 10.1016/j.canlet.2016.07.017;

Gari HH, Gearheart CM, Fosmire S, DeGala GD, Fan Z, Torkko KC, Edgerton SM, Lucia MS, Ray R, Thor AD, Porter CC, Lambert JR. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers. Oncotarget. 2016 Mar 29; 7(13):15757-71. PMID: 26909599; PMCID: PMC4941275; DOI: 10.18632/oncotarget.7462;

Gari HH, Ray R, Lucia S, Porter CC, Gearheart CM, Fosmire S, Degala GD, Fan Z, Ru Y, Thor AD, Lambert JR. Cancer Research. Abstract 4604: PTP4A3 is oncogenic and modulates triple negative breast cancer growth. 2014; 74(19):4604. View Publication

Datta-Mitra A, Mitra A, Ray R, Raychaudhuri SP, Kundu-Raychaudhuri S. 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade. Int Immunopharmacol. 2013 Nov; 17(3):744-51. PMID: 24036370; DOI: 10.1016/j.intimp.2013.08.009;

Datta Mitra A, Raychaudhuri SP, Abria CJ, Mitra A, Wright R, Ray R, Kundu-Raychaudhuri S. 1a,25-Dihydroxyvitamin-D3-3-bromoacetate regulates AKT/mTOR signaling cascades: a therapeutic agent for psoriasis. J Invest Dermatol. 2013 Jun; 133(6):1556-64. PMID: 23314787; DOI: 10.1038/jid.2013.3;

Sadler S, Ray R, Jones GB. Designed PDT agents: Synthesis and biological evaluation of steroid-porphyrin conjugates. 2012.

Ray R, Banks M, Abuzahra H, Eddy VJ, Persons KS, Lucia MS, Lambert JR, Holick MF. Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model. Anticancer Res. 2012 Mar; 32(3):727-31.View Related Profiles.

Banks, Mara
Holick, Michael
Ray, Rahul

PMID: 22399584; PMCID: PMC4681513

Sadler S, Persons KS, Jones GB, Ray R. Internalization of a C17a-alkynylestradiol-porphyrin conjugate into estrogen receptor positive MCF-7 breast cancer cells. Bioorg Med Chem Lett. 2011 Aug 1; 21(15):4638-41. PMID: 21704522; DOI: 10.1016/j.bmcl.2011.05.094;

Ray R, Lambert JR. 1a,25-Dihydroxyvitamin D3-3ß-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action. Bioorg Med Chem Lett. 2011 Apr 15; 21(8):2537-40. PMID: 21392983; PMCID: PMC3073821; DOI: 10.1016/j.bmcl.2011.02.025;

Ray R, Lambert JR, Persons KS, Eddy VJ. Cancer Research. Abstract 5533: Anti-proliferative and anti-tumor effects of a novel vitamin D derivative, either alone or in a liposomal formulation in malignancies of kidney, pancreas and prostate. 2011; 70(8):5533. View Publication

Showing 10 of 76 results. Show More

Lambert JR, Eddy VJ, Young CD, Persons KS, Sarkar S, Kelly JA, Genova E, Lucia MS, Faller DV, Ray R. A vitamin D receptor-alkylating derivative of 1a,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth. Cancer Prev Res (Phila). 2010 Dec; 3(12):1596-607.View Related Profiles.

Faller, Douglas
Ray, Rahul
Sarkar, Sibaji

PMID: 21149334; PMCID: PMC3059596; DOI: 10.1158/1940-6207.CAPR-10-0122;

Sadler S, Ray R, Jones GB. Synthesis of steroid-porphyrin conjugates as PDT agents. 2010.

Persons KS, Eddy VJ, Chadid S, Deoliveira R, Saha AK, Ray R. Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells. Anticancer Res. 2010 Jun; 30(6):1875-80.View Related Profiles.

Saha, Asish
Ray, Rahul
Chadid, Susan

PMID: 20651329

Purohit A, Wyatt J, Hynd G, Wright J, El-Shafey A, Swamy N, Ray R, Jones GB. ChemInform Abstract: Chemical Synthesis of Hormone Receptor Probes: High Affinity Photoactivated Enediyne-Estrogens. ChemInform. 2010; 33(9). View Publication
Persons KS, Hareesh S, Eddy VJ, Ray R. Liposomal 1,25-dihydroxyvitamin D3-3-bromoacetate is a Stronger Growth-inhibiting Agent than its unencapsulated Counterpart in Prostate Cancer Cells. 2010. View Publication

Kaya T, Swamy N, Persons KS, Ray S, Mohr SC, Ray R. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications. Bioorg Chem. 2009 Apr; 37(2):57-63. PMID: 19223058; PMCID: PMC2696187; DOI: 10.1016/j.bioorg.2009.01.001;

Swamy N, Ray R. Fatty acid-binding site environments of serum vitamin D-binding protein and albumin are different. Bioorg Chem. 2008 Jun; 36(3):165-8. PMID: 18374965; PMCID: PMC2490816; DOI: 10.1016/j.bioorg.2008.02.002;

Ray A, Swamy N, Ray R. Cross-talk among structural domains of human DBP upon binding 25-hydroxyvitamin D. Biochem Biophys Res Commun. 2008 Jan 25; 365(4):746-50. PMID: 18035050; PMCID: PMC2174211; DOI: 10.1016/j.bbrc.2007.11.033;

Lambert JR, Young CD, Persons KS, Ray R. Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells. Biochem Biophys Res Commun. 2007 Sep 14; 361(1):189-95. PMID: 17658477

Swamy N, Purohit A, Fernandez-Gacio A, Jones GB, Ray R. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate. J Cell Biochem. 2006 Oct 15; 99(3):966-77. PMID: 16741968

Fernandez Gacio A, Fernandez-Marcos C, Swamy N, Dunn D, Ray R. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate. J Cell Biochem. 2006 Oct 15; 99(3):665-70. PMID: 16795032

Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray R. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clin Cancer Res. 2004 Dec 1; 10(23):8018-27.View Related Profiles.

Holick, Michael
Ray, Rahul
Chen, Tai

PMID: 15585637

Ray R, Swamy N, Chen TC, Peleg S, Christakos S, Weigel N. Journal of Bone and Mineral Research. A novel 25-hydroxyvitamin D-3 analog for prostate cancer . 2003; 18.

Swamy N, Persons KS, Chen TC, Ray R. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells. J Cell Biochem. 2003 Aug 1; 89(5):909-16.View Related Profiles.

Ray, Rahul
Chen, Tai

PMID: 12874825

Fernández-Gacio A, Fernández-Marcos C, Swamy N, Ray R. Affinity labeling of the nuclear vitamin D receptor with nonsteroidal alkylating agents. Bioorg Med Chem Lett. 2003 Jan 20; 13(2):213-6. PMID: 12482426

Kisker O, Onizuka S, Becker CM, Fannon M, Flynn E, D'Amato R, Zetter B, Folkman J, Ray R, Swamy N, Pirie-Shepherd S. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. Neoplasia. 2003 Jan-Feb; 5(1):32-40. PMID: 12659668; PMCID: PMC1502120

Hussain EA, Mehta RR, Ray R, Das Gupta TK, Mehta RG. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy. Recent Results Cancer Res. 2003; 164:393-411. PMID: 12899538

Swamy N, James DA, Mohr SC, Hanson RN, Ray R. An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells. Bioorg Med Chem. 2002 Oct; 10(10):3237-43. PMID: 12150869

Head JF, Swamy N, Ray R. Crystal structure of the complex between actin and human vitamin D-binding protein at 2.5 A resolution. Biochemistry. 2002 Jul 23; 41(29):9015-20.View Related Profiles.

Head, James
Ray, Rahul

PMID: 12119014

Swamy N, Head JF, Weitz D, Ray R. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein. Arch Biochem Biophys. 2002 Jun 1; 402(1):14-23.View Related Profiles.

Head, James
Ray, Rahul

PMID: 12051678

Addo JK, Swamy N, Ray R. The C(19) position of 25-hydroxyvitamin D(3) faces outward in the vitamin D sterol-binding pocket of vitamin D-binding protein. Bioorg Med Chem Lett. 2002 Feb 11; 12(3):279-81. PMID: 11814777

Mohr SC, Swamy N, Xu W, Ray R. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1a,25-dihydroxyvitamin D3 receptor?. Steroids. 2001. View Publication

Swamy N, Ghosh S, Schneider GB, Ray R. Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-maf) activates osteoclasts and binding of 25-hydroxyvitamin D(3) does not influence this activity. J Cell Biochem. 2001; 81(3):535-46. PMID: 11255236

Baran DT, Quail JM, Ray R, Honeyman T. Binding of 1alpha,25-dihydroxyvitamin D(3) to annexin II: effect of vitamin D metabolites and calcium. J Cell Biochem. 2000 Oct 20; 80(2):259-65. PMID: 11074597

Swamy N, Xu W, Paz N, Hsieh JC, Haussler MR, Maalouf GJ, Mohr SC, Ray R. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3. Biochemistry. 2000 Oct 10; 39(40):12162-71. PMID: 11015194

Rao LS, Ray R, Holick MF, Horst RL, Uskokovic MR, Reddy GS. Metabolism of [3alpha-3H] 25-hydroxyvitamin D2 in kidneys isolated from normal and vitamin D2-intoxicated rats. J Nutr Sci Vitaminol (Tokyo). 2000 Oct; 46(5):222-9.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 11234914

Addo J, Swamy N, Ray R. Erratum to ‘C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1a,25-dihydroxyvitamin D3: Synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor1: [steroids 64 (1999) 273–282]. Steroids. 2000; 65(4):225. View Publication

Baran DT, Quail JM, Ray R, Leszyk J, Honeyman T. Annexin II is the membrane receptor that mediates the rapid actions of 1alpha,25-dihydroxyvitamin D(3). J Cell Biochem. 2000 Apr; 78(1):34-46. PMID: 10797564

Swamy N, Addo JK, Ray R. Development of an affinity-driven cross-linker: isolation of a vitamin D receptor associated factor. Bioorg Med Chem Lett. 2000 Feb 21; 10(4):361-4. PMID: 10714500

Swamy N, Addo J, Vskokovic MR, Ray R. Probing the vitamin D sterol-binding pocket of human vitamin D-binding protein with bromoacetate affinity labeling reagents containing the affinity probe at C-3, C-6, C-11, and C-19 positions of parent vitamin D sterols. Arch Biochem Biophys. 2000 Jan 15; 373(2):471-8. PMID: 10620374

Chen ML, Ray S, Swamy N, Holick MF, Ray R. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3). Arch Biochem Biophys. 1999 Oct 1; 370(1):34-44.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 10496974

James DA, Swamy N, Paz N, Hanson RN, Ray R. Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer. Bioorg Med Chem Lett. 1999 Aug 16; 9(16):2379-84. PMID: 10476873

Addo JK, Swamy N, Ray R. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor. Steroids. 1999 Apr; 64(4):273-82. PMID: 10399884

Swamy N, Mohr SC, Xu W, Ray R. Vitamin D receptor interacts with DnaK/heat shock protein 70: identification of DnaK interaction site on vitamin D receptor. Arch Biochem Biophys. 1999 Mar 15; 363(2):219-26. PMID: 10068443

Ray R. Molecular recognition and structure-activity relations in vitamin D-binding protein and vitamin D receptor . 1999.

Addo JK, Ray R. Synthesis and binding-analysis of 5E-[19-(2-bromoacetoxy)methyl]25-hydroxyvitamin D3 and 5E-25-hydroxyvitamin D3-19-methyl[(4-azido-2-nitro)phenyl]glycinate: novel C19-modified affinity and photoaffinity analogs of 25-hydroxyvitamin D3. Steroids. 1998 Apr; 63(4):218-23. PMID: 9589557

Baran D, Quail J, Ray R, Leszyk J, Honeyman T. Identification of the membrane protein that binds 1a,25-dihydroxyvitamin D3 and is involved in the rapid actions of the hormone. Bone. 1998; 23:S173.

Swamy N, Kounine M, Ray R. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent. Arch Biochem Biophys. 1997 Dec 1; 348(1):91-5. PMID: 9390178

Swamy N, Dutta A, Ray R. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein. Biochemistry. 1997 Jun 17; 36(24):7432-6. PMID: 9200691

Swamy N, Ghosh S, Ray R. Bacterial expression of human vitamin D-binding protein (Gc2) in functional form. Protein Expr Purif. 1997 Jun; 10(1):115-22. PMID: 9179298

Ray R, Holick MF. Synthesis of [3 alpha-3H]vitamin D3 and 1 alpha,25-dihydroxy[1 beta-3H]vitamin D3. Methods Enzymol. 1997; 282:157-64.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 9330285

Swamy N, Ray R. Affinity labeling of rat serum vitamin D binding protein. Arch Biochem Biophys. 1996 Sep 1; 333(1):139-44. PMID: 8806764

Ray R. Molecular recognition in vitamin D-binding protein. Proc Soc Exp Biol Med. 1996 Sep; 212(4):305-12. PMID: 8751987

Fleet JC, Bradley J, Reddy GS, Ray R, Wood RJ. 1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro. Arch Biochem Biophys. 1996 May 15; 329(2):228-34. PMID: 8638956; DOI: 10.1006/abbi.1996.0213;

Ray R, Swamy N, MacDonald PN, Ray S, Haussler MR, Holick MF. Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor. J Biol Chem. 1996 Jan 26; 271(4):2012-7.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 8567652

Ray S, Ray R, Holick MF. Metabolism of 3H-1 alpha,25-dihydroxyvitamin D3 in cultured human keratinocytes. J Cell Biochem. 1995 Sep; 59(1):117-22.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 8530531

Roy A, Ray R. Aminopropylation of vitamin D hormone (1 alpha,25-dihydroxyvitamin D3), its biological precursors, and other steroidal alcohols: an anchoring moiety for affinity studies of sterols. Steroids. 1995 Aug; 60(8):530-3. PMID: 8539795

Swamy N, Ray R. 25-Hydroxy[26,27-methyl-3H]vitamin D3-3 beta-(1,2-epoxypropyl)ether: an affinity labeling reagent for human vitamin D-binding protein. Arch Biochem Biophys. 1995 Jun 1; 319(2):504-7. PMID: 7786034

Swamy N, Roy A, Chang R, Brisson M, Ray R. Affinity purification of human plasma vitamin D-binding protein. Protein Expr Purif. 1995 Apr; 6(2):185-8. PMID: 7606167

Swamy N, Brisson M, Ray R. Trp-145 is essential for the binding of 25-hydroxyvitamin D3 to human serum vitamin D-binding protein. J Biol Chem. 1995 Feb 10; 270(6):2636-9. PMID: 7852330

Baran DT, Ray R, Sorensen AM, Honeyman T, Holick MF. Journal of Cellular Biochemistry. Binding characteristics of a membrane receptor that recognizes 1a,25-Dihydroxyvitamin D3 and its epimer, 1b,25-Dihydroxyvitamin D3. 1994; 56(4):510-517. View Publication
Ray R, Ray S, Holick MF. 1a,25-Dihydroxyvitamin D3-3ß-bromoacetate, an Affinity-Labeling Analog of 1a,25-Dihydroxyvitamin D3 Receptor. Bioorganic Chemistry. 1994; 22(3):276-283. View Publication

Ray R, Ray S, Rose S, Holick MF. Photoaffinity labeling of chick intestinal 1 alpha,25-dihydroxyvitamin D3 receptor. Steroids. 1993 Oct; 58(10):462-5.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 8256255

Vicchio D, Yergey A, O'Brien K, Allen L, Ray R, Holick M. Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom. 1993 Jan; 22(1):53-8.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 8431502

Ray R, Vicchio D, Yergey A, Holick MF. Synthesis of 25-hydroxy-[6,19,19'-2H3]vitamin D3 and 1 alpha,25-dihydroxy-[6,19,19'-2H3]vitamin D3. Steroids. 1992 Mar; 57(3):142-6.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 1621268

Ray R, Bouillon R, Van Baelen H, Holick MF. Photoaffinity labeling of human serum vitamin D binding protein and chemical cleavages of the labeled protein: identification of an 11.5-kDa peptide containing the putative 25-hydroxyvitamin D3 binding site. Biochemistry. 1991 Jul 30; 30(30):7638-42.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 1854759

Ray R, Bouillon R, Van Baelen H, Holick MF. Synthesis of 25-hydroxyvitamin D3 3 beta-3'-[N-(4-azido-2-nitrophenyl)amino]propyl ether, a second-generation photoaffinity analogue of 25-hydroxyvitamin D3: photoaffinity labeling of rat serum vitamin D binding protein. Biochemistry. 1991 May 14; 30(19):4809-13.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 2029522

Baran DT, Sorensen AM, Honeyman TW, Ray R, Holick MF. 1a,25-Dihydroxyvitamin D3-induced increments in hepatocyte cytosolic calcium and lysophosphatidylinositol: Inhibition by pertussis toxin and 1ß,25-dihydroxyvitamin D3. Journal of Bone and Mineral Research. 1990; 5(5):517-524. View Publication

Baran DT, Sorensen AM, Honeyman TW, Ray R, Holick MF. Rapid actions of 1 alpha,25-dihydroxyvitamin D3 on Ca2+ and phospholipids in isolated rat liver nuclei. FEBS Lett. 1989 Dec 18; 259(1):205-8.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 2599107

Makin G, Lohnes D, Byford V, Ray R, Jones G. Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J. 1989 Aug 15; 262(1):173-80. PMID: 2818561; PMCID: PMC1133244

Ray R, Holick MF. The synthesis of a radiolabeled photoaffinity analog of 1,25-dihydroxyvitamin D3. Steroids. 1988 May-Jun; 51(5-6):623-30.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 3242181

Reddy SC, Ray R, DeCosta B, Holick MF. A NOVEL METABOLIC PATHWAY FOR 25???HYDROXYVITAMIN D2 IN A MAMMALIAN KIDNEY. Pediatric Research. 1987; 4(1). View Publication

Ray R, Holick SA, Hanafin N, Holick MF. Photoaffinity labeling of the rat plasma vitamin D binding protein with [26,27-3H]-25-hydroxyvitamin D3 3 beta-[N-(4-azido-2-nitrophenyl)glycinate]. Biochemistry. 1986 Aug 26; 25(17):4729-33.View Related Profiles.

Holick, Michael
Ray, Rahul

PMID: 3768308

Ray R, Rose S, Holick SA, Holick MF. Evaluation of a photolabile derivative of 1,25-dihydroxyvitamin D3 as a photoaffinity probe for 1,25-dihydroxyvitamin-D3 receptor in chick intestinal cytosol. Biochemical and Biophysical Research Communications. 1985; 132(1):198-203. View Publication
Ray R, Holick SA, Holick MF. Synthesis of a photoaffinity-labelled analogue of 1,25-dihydroxyvitamin D3. Journal of the Chemical Society Chemical Communications. 1985; 11(11). View Publication
Sadler S, Ray R, Jones GB. Preparation and evaluation of steroid-porphyrin conjugates as PDT agents.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 75 publications over 30 distinct years, with a maximum of 7 publications in 2000

Bar chart showing 75 publications over 30 distinct years, with a maximum of 7 publications in 2000

Year	Publications
1985	2
1986	1
1987	1
1988	1
1989	2
1990	1
1991	2
1992	1
1993	2
1994	2
1995	5
1996	4
1997	4
1998	2
1999	5
2000	7
2001	2
2002	4
2003	5
2004	1
2006	2
2007	2
2008	1
2009	1
2010	5
2011	3
2012	2
2013	2
2014	1
2016	2

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Grant writing
Translational research

Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map

Download vCard

Ray's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (265) concept(s)

Co-Authors

See all (4) people

Similar People

See all (60) people

Same Department

Search Department